RANP1

Across TCGA pan-cancer cohorts, RANP1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RANP1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RANP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RANP1 expression acts as an unfavorable survival marker, although some lineages such as READ and THCA show a favorable association.

LIHC, ACC, and LGG are the cancer types where RANP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.388	0.611	<.001	97	view →
ACC	DFS	Median	All	0.393	0.767	<.001	78	view →
LGG	OS	Median	All	0.730	0.926	<.001	34	view →
LUAD	OS	Median	All	0.774	0.848	.011	23	view →
KICH	DFS	Median	II,III,IV	0.555	0.922	.003	23	view →
READ	DFS	Median	III,IV	0.883	0.618	.001	22	view →
SARC	OS	Quartile	All	0.367	0.642	<.001	20	view →
UVM	DFS	Quartile	III,IV	0.241	0.856	.013	19	view →
THCA	OS	Median	II,III,IV	1.000	0.924	.006	16	view →
BRCA	OS	Quartile	II,III,IV	0.465	0.621	.005	15	view →
MESO	OS	Median	IV	0.294	0.742	.004	14	view →
CESC	OS	Tertile	II,III,IV	0.826	0.447	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

RANP1–LIHC (DFS)

Open the LIHC breakdown →